Fixed income offering ‘no place to hide’ for Payden & Rygel
There is “no place to hide” in fixed income in the event of a liquidity crisis, according to US-based investment manager Payden & Rygel.
The US bond specialist said it had opted to go into government bonds this year in light of the market downturn caused by the COVID-19 pandemic but that was not a solution for the fund in the long term. The yield on US 10-year Treasuries was currently 0.93%.
Portfolio manager Eric Sounders said in a webcast: “There is no place to hide in fixed income when weird things are happening with liquidity. The only thing that did well was long-dated government bonds but this is not a prudent strategy in the long term.
“The people who are going into government bonds need to realise that this is not good in the long term.”
The GSFM Payden Global Income Opportunities fund had 65% invested in investment grade and 8% in high yield as Sounders said he was cautious about parts of the high yield market that had been affected by COVID-19. Around 30% of the portfolio was invested in BBB-rated assets while 20% was in AAA ones.
In its latest factsheet, it said: “The strategy maintains a preference toward securitised product versus corporate credit in COVID resilient industries and remains cautiously optimistic in areas like high-yield corporates, bank loans, and commercial real estate, as default risk is still elevated.
“The strategy’s participation within the corporate credit market remained thin, while we continued to prefer securitised product given the strength in US housing, low rate environment, and lesser virus or election-related headline risk.”
The fund had lost 0.22% over one year to 30 November, 2020, according to FE Analytics, versus returns of 3.8% by the Australian Core Strategies absolute return sector.
AUTHOR
Laura Dew
Recommended for you
Australian equity ETFs attracted record inflows of $3.2 billion in 1Q25, while heightened volatility led to a decline in flows for global equity ETFs, according to Vanguard.
The failure of a clinical trial by biotech firm Opthea has caused shares in its backer Regal Partners to decline 52 per cent year-to-date and hit its funds under management, quarterly flows show.
GQG Partners has revealed its quarterly flows for the first three months of 2025 were up 5.8 per cent, after a difficult final quarter of 2024 as a result of institutional redemptions.
Global asset manager Janus Henderson has signed a strategic partnership with life insurer Guardian Life, which will commit US$400 million to accelerate the firm’s fixed income development plans.
